A protein called SYNCRIP helps glioblastoma cells stay alive
Original title: SYNCRIP drives ferroptosis resistance and metabolic activation via SIRT1 and HK2 in glioblastoma.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was done on cells in a lab, not in people. It is a very early step.
This was early lab work on cells and tumor samples, not a treatment given to patients.
The short version
Lab work found a protein that helps glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells resist dying, which makes it a possible target for future drugs.
What was studied. Researchers studied a protein called SYNCRIP in glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary, a brain tumor. They looked at how much of it tumors make, and what happens to tumor cells when it is removed.
What they found. glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary had high levels of SYNCRIP, and higher levels went along with worse outcomes and more tumor growth. When SYNCRIP was taken away, the cells built up harmful waste and began to die off in a specific way. The cells also had trouble making energy, and they moved and spread less.
What this means, and what it doesn't
What it could mean: This points to SYNCRIP as a possible target for a future drug. Blocking it might make glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary cells easier to kill. Right now this is only an idea for researchers to test.
What it doesn't mean: This does not mean there is a new treatment. This was early lab science, not a study in people. No drug that blocks SYNCRIP was tested in patients here. It is not a cure, and it is a long way from anything a doctor could offer you. Most findings at this stage never become a treatment.
Source: PubMed, July 13, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.